5mn.ch is owned and operated by EneroBio, Richtistrasse 2, 8304 Wallisellen, Switzerland. “5mn”, “we”, “us” and “our” refer to EneroBio and to the analysts who publish on 5mn.
Who 5mn Research is for
5mn Research, meaning the Spotlights and the valuation models, is directed only at professional and institutional investors that meet one of the following qualifications and have relevant professional experience. It should not be acted on or relied on by any other person.
- Switzerland: legal entities that qualify as institutional clients under Article 4(4) or as professional clients under Article 4(3) of the Federal Act on Financial Services (FinSA).
- United Kingdom: legal entities authorised by the PRA or FCA, other investment professionals within Article 19(5), or high net worth companies within Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005.
- European Union and EEA: legal entities that qualify as professional clients or eligible counterparties under Directive 2014/65/EU (MiFID II).
Spotlights are made available free of charge and at the same time to all such investors who wish to receive them.
The Daily Brief and Insights report news and general information and are open to all readers.
General information only
Everything 5mn publishes, on this website and by email, is general information, prepared without regard to the investment objectives, financial situation or means of any reader. It is not financial, investment or other professional advice. Nothing 5mn publishes is an offer, solicitation or recommendation to buy, sell or hold any security or other financial instrument, or to follow any investment strategy. Certain investments carry substantial risk and are not suitable for all investors. Readers make their own investment decisions and bear the risks of them.
Accuracy and availability
5mn’s content is based on company releases, regulatory documents and other sources believed to be reliable. We take reasonable care that it is accurate at the time of publication, but 5mn has not independently verified this information and does not represent that it is accurate, complete or current, and it should not be relied upon as such. Views and estimates may change without notice.
This website, our emails and their content are provided strictly “as is” and “as available”. To the extent permitted by law, we exclude all warranties, conditions, representations and terms, whether express or implied by law or otherwise, including as to accuracy, completeness, suitability, availability and freedom from errors or viruses.
We may suspend access to this website, or change or discontinue any part of it, at any time and without notice. We accept no liability for interruptions, delays, or late, missed or misdirected emails.
Paid Spotlights and conflicts of interest
Some Spotlights are commissioned and paid for by the company covered; others are written independently, without payment. Where a company has paid, this is stated at the top of the Spotlight. Fees are agreed in advance and do not depend on the conclusions, and the company covered has no say over them.
5mn does not cover companies it advises, and 5mn and its analysts hold no positions in the companies covered.
Liability
Forecasts and valuations are subject to significant uncertainty, and past performance is not a reliable indicator of future results. To the extent permitted by law, 5mn and its analysts shall not be liable to any person or organisation for any direct, indirect, special, incidental or consequential loss or damage, whether in contract, tort (including negligence) or otherwise, arising in any way from or in connection with the use of this website, our emails or their content. This includes any act or omission in reliance on that information or on any linked third-party website.
Jurisdictions
This information is not directed at, or intended for distribution to or use by, any person or entity in any jurisdiction where such distribution or use would be contrary to law or regulation, or would subject 5mn to any registration or licensing requirement there, in particular the United States.
Use of our content
All content on 5mn, including text, data, charts, tables, models and illustrations, belongs to EneroBio or its licensors.
You may read, print, save and share our pages and emails, and quote from them, as long as you name 5mn as the source and, where possible, link to the original page. Search engines and AI assistants may index, summarise and quote our public pages on the same terms.
You may not republish our content in full, sell it, present it as your own or alter it in a way that changes its meaning without our written permission. Material reserved for subscribers, such as our valuation models, is for use within the subscriber’s own organisation and may not be passed on.
Links to other websites
Our pages and emails link to company releases and other third-party websites so that readers can check our sources. We do not control those websites and are not responsible for their content or availability.
Acceptance
By continuing to use this website or by subscribing to 5mn emails, you accept these terms. If you do not agree with them, please do not use this website.